Biora Therapeutics, Inc. - Common Stock (NQ: BIOR )
0.6556
+0.0723
(+12.39%)
Streaming Delayed Price
Updated: 10:26 AM EDT, Aug 13, 2024
Add to My Watchlist
All News about Biora Therapeutics, Inc. - Common Stock
![](https://investorplace.com/wp-content/uploads/2019/08/pills.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_725.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
January 11, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/01/11/image_2.jpg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2021/05/wall-street-morning.jpg)
Looking Into Biora Therapeutics's Return On Invested Capital
December 27, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/01/10/shutterstock_1928774615.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/01/10/image49.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_660.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Tuesday's Intraday Session
January 10, 2023
Via Benzinga
![](https://ml.globenewswire.com/media/74f7c790-2ce7-4964-8bc9-9a41f6818600/small/biora-tm-rgb-jpg.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_96.jpeg?width=1200&height=800&fit=crop)
Stocks That Hit 52-Week Lows On Tuesday
January 03, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_415.jpeg?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/74f7c790-2ce7-4964-8bc9-9a41f6818600/small/biora-tm-rgb-jpg.jpg)
Biora Therapeutics Announces Reverse Stock Split
December 30, 2022
Via GlobeNewswire
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_303.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/12/16/image-adobe.png?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/74f7c790-2ce7-4964-8bc9-9a41f6818600/small/biora-tm-rgb-jpg.jpg)
![](https://ml.globenewswire.com/media/74f7c790-2ce7-4964-8bc9-9a41f6818600/small/biora-tm-rgb-jpg.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/11/18/image_3.jpg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/11/21/image_5.jpg?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/74f7c790-2ce7-4964-8bc9-9a41f6818600/small/biora-tm-rgb-jpg.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/11/18/image13.jpg?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/74f7c790-2ce7-4964-8bc9-9a41f6818600/small/biora-tm-rgb-jpg.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/11/08/image16.jpg?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/74f7c790-2ce7-4964-8bc9-9a41f6818600/small/biora-tm-rgb-jpg.jpg)
Biora Therapeutics Announces $9.75 Million Direct Offering
November 07, 2022
Via GlobeNewswire
![](https://cdn.benzinga.com/files/images/story/2022/11/07/image14.jpg?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/74f7c790-2ce7-4964-8bc9-9a41f6818600/small/biora-tm-rgb-jpg.jpg)
Biora Therapeutics Announces Sale of Cell-Free DNA Patent Rights
October 27, 2022
Via GlobeNewswire
![](https://ml.globenewswire.com/media/74f7c790-2ce7-4964-8bc9-9a41f6818600/small/biora-tm-rgb-jpg.jpg)
![](https://ml.globenewswire.com/media/74f7c790-2ce7-4964-8bc9-9a41f6818600/small/biora-tm-rgb-jpg.jpg)
![](https://ml.globenewswire.com/media/74f7c790-2ce7-4964-8bc9-9a41f6818600/small/biora-tm-rgb-jpg.jpg)
Via GlobeNewswire
![](https://ml.globenewswire.com/media/74f7c790-2ce7-4964-8bc9-9a41f6818600/small/biora-tm-rgb-jpg.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.